|
Volumn 19, Issue 1, 2001, Pages 29-35
|
Hydroxychloroquine sulphate inhibits in vitro apoptosis of circulating lymphocytes in patients with systemic lupus erythematosus
a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
AUTOANTIBODY;
CELL NUCLEUS ANTIGEN;
DNA ANTIBODY;
DOUBLE STRANDED DNA;
HYDROXYCHLOROQUINE SULFATE;
ADULT;
ANTIGEN PRESENTATION;
ANTIGEN PRESENTING CELL;
APOPTOSIS;
ARTICLE;
CELL STRUCTURE;
CLINICAL ARTICLE;
CLINICAL FEATURE;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONCENTRATION RESPONSE;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFECT;
FEMALE;
FLUORESCENCE ACTIVATED CELL SORTER;
HUMAN;
HUMAN CELL;
IN VITRO STUDY;
INHIBITION KINETICS;
MACROPHAGE;
MONOCYTE;
NUCLEOSOME;
PATHOPHYSIOLOGY;
PERIPHERAL LYMPHOCYTE;
SYSTEMIC LUPUS ERYTHEMATOSUS;
ACRIDINE ORANGE;
ADULT;
APOPTOSIS;
CELL SEPARATION;
CELL SURVIVAL;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
FLOW CYTOMETRY;
FLUORESCENT DYES;
HUMANS;
HYDROXYCHLOROQUINE;
LUPUS ERYTHEMATOSUS, SYSTEMIC;
LYMPHOCYTES;
PROPIDIUM;
STAINING AND LABELING;
TIME FACTORS;
WOMEN'S HEALTH;
|
EID: 0034926012
PISSN: 0125877X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (13)
|
References (19)
|